Desmin-related myofibrillar myopathy
| Desmin-related myofibrillar myopathy | |
|---|---|
| Synonyms | Desminopathy |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Muscle weakness, muscle pain, cardiomyopathy, respiratory difficulties |
| Complications | N/A |
| Onset | Typically in adulthood, but can vary |
| Duration | Progressive |
| Types | N/A |
| Causes | Mutations in the DES gene |
| Risks | Family history of the condition |
| Diagnosis | Muscle biopsy, Genetic testing |
| Differential diagnosis | Other forms of myopathy, muscular dystrophy |
| Prevention | N/A |
| Treatment | Supportive care, physical therapy, management of cardiac and respiratory symptoms |
| Medication | N/A |
| Prognosis | Variable, depends on severity and progression |
| Frequency | Rare |
| Deaths | N/A |
Desmin-related myofibrillar myopathy (DRM) is a type of myopathy that primarily affects the skeletal muscles and cardiac muscle. It is characterized by the accumulation of desmin, a type of intermediate filament protein, in muscle cells. This condition is a subtype of the broader category of myofibrillar myopathies.
Etiology[edit]
DRM is caused by mutations in the DES gene, which provides instructions for making desmin. Desmin is a protein that plays a crucial role in maintaining the structural integrity and proper functioning of muscle cells. Mutations in the DES gene disrupt the normal assembly of desmin proteins into intermediate filaments, leading to the formation of abnormal aggregates of desmin and other proteins in muscle cells.
Clinical Features[edit]
The clinical features of DRM can vary widely among affected individuals. Symptoms typically begin in adulthood and can include muscle weakness and wasting, cardiac abnormalities such as cardiomyopathy, and respiratory problems. In some cases, DRM can also affect the nerves, leading to neuropathy.
Diagnosis[edit]
Diagnosis of DRM is based on clinical symptoms, family history, and specialized tests such as muscle biopsy and genetic testing. A muscle biopsy can reveal the characteristic desmin aggregates in muscle cells, while genetic testing can identify mutations in the DES gene.
Treatment[edit]
There is currently no cure for DRM. Treatment is symptomatic and supportive, and may include physical therapy, respiratory support, and management of cardiac complications.
Prognosis[edit]
The prognosis for individuals with DRM varies depending on the severity of symptoms and the presence of cardiac involvement. Some individuals may have a normal lifespan with mild symptoms, while others may experience severe disability and life-threatening cardiac complications.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian